Dysfunctional uterine bleeding secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m corrected my personal editor hyperlink |
|||
| Line 9: | Line 9: | ||
[[DUB]]-based complications can be treated by: | [[DUB]]-based complications can be treated by: | ||
*[[Infertility]]: treat the underlying cause; since medical treatment is often hormonal and would prevent fertility, surgical treatment is opted for. This includes removal of any structural [[masses]] preventing fertility <ref name="pmid15117012">{{cite journal| author=Albers JR, Hull SK, Wesley RM| title=Abnormal uterine bleeding. | journal=Am Fam Physician | year= 2004 | volume= 69 | issue= 8 | pages= 1915-26 | pmid=15117012 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15117012 }}</ref> | *[[Infertility]]: treat the underlying cause; since medical treatment is often hormonal and would prevent fertility, surgical treatment is opted for. This includes removal of any structural [[masses]] preventing fertility<ref name="pmid15117012">{{cite journal| author=Albers JR, Hull SK, Wesley RM| title=Abnormal uterine bleeding. | journal=Am Fam Physician | year= 2004 | volume= 69 | issue= 8 | pages= 1915-26 | pmid=15117012 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15117012 }}</ref> | ||
*[[Anemia]]: supplemental [[Iron supplements|iron]] treatment <ref name="pmid28846348">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846348 | doi= | pmc= | url= }} </ref> | *[[Anemia]]: supplemental [[Iron supplements|iron]] treatment<ref name="pmid28846348">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846348 | doi= | pmc= | url= }} </ref> | ||
*[[Uterine cancer|Malignancy]]: prevent excess [[estrogen]] exposure with the use of [[hormonal contraceptive medications]]; avoid use of [[hormonal replacement therapy]] <ref name="pmid27451318">{{cite journal| author=Sjögren LL, Mørch LS, Løkkegaard E| title=Hormone replacement therapy and the risk of endometrial cancer: A systematic review. | journal=Maturitas | year= 2016 | volume= 91 | issue= | pages= 25-35 | pmid=27451318 | doi=10.1016/j.maturitas.2016.05.013 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27451318 }} </ref> | *[[Uterine cancer|Malignancy]]: prevent excess [[estrogen]] exposure with the use of [[hormonal contraceptive medications]]; avoid use of [[hormonal replacement therapy]]<ref name="pmid27451318">{{cite journal| author=Sjögren LL, Mørch LS, Løkkegaard E| title=Hormone replacement therapy and the risk of endometrial cancer: A systematic review. | journal=Maturitas | year= 2016 | volume= 91 | issue= | pages= 25-35 | pmid=27451318 | doi=10.1016/j.maturitas.2016.05.013 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27451318 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 01:27, 7 August 2022
|
Dysfunctional uterine bleeding Microchapters |
|
Differentiating Dysfunctional uterine bleeding from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Dysfunctional uterine bleeding secondary prevention On the Web |
|
American Roentgen Ray Society Images of Dysfunctional uterine bleeding secondary prevention |
|
Dysfunctional uterine bleeding secondary prevention in the news |
|
Blogs on Dysfunctional uterine bleeding secondary prevention |
|
Directions to Hospitals Treating Dysfunctional uterine bleeding |
|
Risk calculators and risk factors for Dysfunctional uterine bleeding secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, M.B.B.S
Overview
Secondary prevention occurs once the disease has developed and aims to prevent progression and development of further complications. Complications due to abnormal uterine bleeding include infertility, anemia, and malignancy.
Secondary prevention
DUB-based complications can be treated by:
- Infertility: treat the underlying cause; since medical treatment is often hormonal and would prevent fertility, surgical treatment is opted for. This includes removal of any structural masses preventing fertility[1]
- Anemia: supplemental iron treatment[2]
- Malignancy: prevent excess estrogen exposure with the use of hormonal contraceptive medications; avoid use of hormonal replacement therapy[3]
References
- ↑ Albers JR, Hull SK, Wesley RM (2004). "Abnormal uterine bleeding". Am Fam Physician. 69 (8): 1915–26. PMID 15117012.
- ↑ "StatPearls". 2022. PMID 28846348.
- ↑ Sjögren LL, Mørch LS, Løkkegaard E (2016). "Hormone replacement therapy and the risk of endometrial cancer: A systematic review". Maturitas. 91: 25–35. doi:10.1016/j.maturitas.2016.05.013. PMID 27451318.